Global Hepatitis B and C Diagnostics Market 2021-2025

Global Hepatitis B and C Diagnostics Market 2021-2025

Technavio has been monitoring the hepatitis B and C diagnostics market and it is poised to grow by USD 1.72 bn during 2021-2025, progressing at a CAGR of 6.22% during the forecast period. Our report on the hepatitis B and C diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growing demand for molecular diagnostics in diagnosis of HBV and HCV and rising demand for POC diagnostics. In addition, the growing demand for molecular diagnostics in diagnosis of HBV and HCV is anticipated to boost the growth of the market as well.

The hepatitis B and C diagnostics market analysis includes the procedure and diseases segment and geographic landscape.

Technavio's hepatitis B and C diagnostics market is segmented as below:

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • ROW
By Procedure
  • Immunodiagnostics
  • NAT
By Diseases
  • Hepatitis B
  • Hepatitis C
This study identifies the strategies of healthcare organizations toward simplifying diagnostic process as one of the prime reasons driving the hepatitis B and C diagnostics market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on hepatitis B and C diagnostics market covers the following areas:
  • Hepatitis B and C diagnostics market sizing
  • Hepatitis B and C diagnostics market forecast
  • Hepatitis B and C diagnostics market industry analysis
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading hepatitis B and C diagnostics market vendors that include Abbott Laboratories, bioMerieux SA, Danaher Corp., DiaSorin SpA, Enzo Biochem Inc., F. Hoffmann-La Roche Ltd., PerkinElmer Inc., QIAGEN N.V, Quest Diagnostics Inc., and Siemens Healthineers AG. Also, the hepatitis B and C diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.


  • Executive Summary
  • Market Landscape
    • Market ecosystem
      • Table Parent market
      • Table Market characteristics
    • Value chain analysis
      • Table Value chain analysis: Life sciences tools and services
      • Research and development
      • Inputs
      • Production
      • Distribution
      • Marketing and sales
      • Post-sales and services
  • Market Sizing
    • Market definition
      • Table Offerings of vendors included in the market definition
    • Market segment analysis
      • Table Market segments
    • Market size 2020
    • Market outlook: Forecast for 2020 - 2025
      • Estimating growth rates for emerging and high-growth markets
      • Estimating growth rates for mature markets
        • Table Global - Market size and forecast 2020 - 2025 ($ million)
        • Table Global market: Year-over-year growth 2020 - 2025 (%)
  • Five Forces Analysis
    • Five forces summary
      • Table Five forces analysis 2020 & 2025
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2020
  • Market Segmentation by Procedure
    • Market segments
      • Table Procedure - Market share 2020-2025 (%)
    • Comparison by Procedure
      • Table Comparison by Procedure
    • Immunodiagnostics - Market size and forecast 2020- 2025
      • Table Immunodiagnostics - Market size and forecast 2020-2025 ($ million)
      • Table Immunodiagnostics - Year-over-year growth 2020-2025 (%)
      • Serological antibody assays
      • Enzyme immunoassay
      • Chemiluminescence immunoassay
      • POC rapid immunoassays
      • Recombinant immunoblot assay
      • Immunofluorescence
      • Instruments
      • Reagents
    • NAT - Market size and forecast 2020-2025
      • Table NAT - Market size and forecast 2020-2025 ($ million)
      • Table NAT - Year-over-year growth 2020-2025 (%)
      • ELISA
    • Market opportunity by Procedure
      • Table Market opportunity by Procedure
  • Market Segmentation by Diseases
    • Market segments
      • Table Diseases - Market share 2020-2025 (%)
    • Comparison by Diseases
      • Table Comparison by Diseases
    • Hepatitis B - Market size and forecast 2020-2025
      • Table Hepatitis B - Market size and forecast 2020-2025 ($ million)
      • Table Hepatitis B - Year-over-year growth 2020-2025 (%)
    • Hepatitis C - Market size and forecast 2020-2025
      • Table Hepatitis C - Market size and forecast 2020-2025 ($ million)
      • Table Hepatitis C - Year-over-year growth 2020-2025 (%)
    • Market opportunity by Diseases
      • Table Market opportunity by Diseases
  • Customer Landscape
    • Table Customer landscape
  • Geographic Landscape
    • Geographic segmentation
      • Table Market share by geography 2020-2025 (%)
    • Geographic comparison
      • Table Geographic comparison
    • North America - Market size and forecast 2020-2025
      • Table North America - Market size and forecast 2020-2025 ($ million)
      • Table North America - Year-over-year growth 2020-2025 (%)
    • Europe - Market size and forecast 2020-2025
      • Table Europe - Market size and forecast 2020-2025 ($ million)
      • Table Europe - Year-over-year growth 2020-2025 (%)
    • Asia - Market size and forecast 2020-2025
      • Table Asia - Market size and forecast 2020-2025 ($ million)
      • Table Asia - Year-over-year growth 2020-2025 (%)
    • ROW - Market size and forecast 2020-2025
      • Table ROW - Market size and forecast 2020-2025 ($ million)
      • Table ROW - Year-over-year growth 2020-2025 (%)
    • Key leading countries
      • Table Key leading countries
    • Market opportunity by geography
      • Table Market opportunity by geography ($ million)
  • Drivers, Challenges, and Trends
    • Market drivers
      • Growing demand for molecular diagnostics in diagnosis of HBV and HCV
      • Strategies of healthcare organizations toward simplifying diagnostic process
      • Rising demand for POC diagnostics
    • Market challenges
      • Low penetration of HBV and HCV diagnostic tests
      • Limited detection capability and complexity of assays
      • Regulatory and reimbursement hurdles limit adoption rate
      • Limitations of closed systems
        • Table Impact of drivers and challenges
    • Market trends
      • Advent of immunosensors in HBV and HCV diagnostic tests
      • High demand for biomarker-based tests
      • Increasing awareness and screening program of HBV and HCV diagnostic tests
  • Vendor Landscape
    • Overview
    • Vendor landscape
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
      • Table Industry risks
  • Vendor Analysis
    • Vendors covered
      • Table Vendors covered
    • Market positioning of vendors
      • Table Market positioning of vendors
    • Abbott Laboratories
      • Table Abbott Laboratories - Overview
      • Table Abbott Laboratories - Business segments
      • Table Abbott Laboratories -Key news
      • Table Abbott Laboratories - Key offerings
      • Table Abbott Laboratories - Segment focus
    • bioMerieux SA
      • Table bioMerieux SA - Overview
      • Table bioMerieux SA - Product and service
      • Table bioMerieux SA-Key news
      • Table bioMerieux SA - Key offerings
    • Danaher Corp.
      • Table Danaher Corp. - Overview
      • Table Danaher Corp. - Business segments
      • Table Danaher -Key news
      • Table Danaher Corp. - Key offerings
      • Table Danaher Corp. - Segment focus
    • DiaSorin SpA
      • Table DiaSorin SpA - Overview
      • Table DiaSorin SpA - Business segments
      • Table DiaSorin SpA-Key news
      • Table DiaSorin SpA - Key offerings
      • Table DiaSorin SpA - Segment focus
    • Enzo Biochem Inc.
      • Table Enzo Biochem Inc. - Overview
      • Table Enzo Biochem Inc. - Business segments
      • Table Enzo Biochem Inc. - Key offerings
      • Table Enzo Biochem Inc. - Segment focus
    • F. Hoffmann-La Roche Ltd.
      • Table F. Hoffmann-La Roche Ltd. - Overview
      • Table F. Hoffmann-La Roche Ltd. - Business segments
      • Table F. Hoffmann La Roche Ltd.- Key news
      • Table F. Hoffmann-La Roche Ltd. - Key offerings
      • Table F. Hoffmann-La Roche Ltd. - Segment focus
    • PerkinElmer Inc.
      • Table PerkinElmer Inc. - Overview
      • Table PerkinElmer Inc. - Business segments
      • Table PerkinElmer Inc -Key news
      • Table PerkinElmer Inc. - Key offerings
      • Table PerkinElmer Inc. - Segment focus
    • QIAGEN N.V
      • Table QIAGEN N.V - Overview
      • Table QIAGEN N.V - Product and service
      • Table QIAGEN N.V-Key news
      • Table QIAGEN N.V - Key offerings
    • Quest Diagnostics Inc.
      • Table Quest Diagnostics Inc. - Overview
      • Table Quest Diagnostics Inc. - Business segments
      • Table Quest Diagnostics Inc. - Key offerings
      • Table Quest Diagnostics Inc. - Segment focus
    • Siemens Healthineers AG
      • Table Siemens Healthineers AG - Overview
      • Table Siemens Healthineers AG - Business segments
      • Table Siemens Healthineers AG-Key news
      • Table Siemens Healthineers AG - Key offerings
      • Table Siemens Healthineers AG - Segment focus
  • Appendix
    • Scope of the report
      • Market definition
      • Objectives
      • Notes and caveats
    • Currency conversion rates for US$
      • Table Currency conversion rates for US$
    • Research methodology
      • Table Research Methodology
      • Table Validation techniques employed for market sizing
      • Table Information sources
    • List of abbreviations
      • Table List of abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings